medigraphic.com
ISSN 2078-7170 (Electronic)

2016, Number 2

<< Back Next >>

CorSalud 2016; 8 (2)

Cardiovascular manifestations in patients treated with periodic hemodialysis through functional arteriovenous fistula

Ayora LAS, Alonso HA, Pérez CD, Ramírez GJI, Cruz ARE

Language: Spanish
References: 42
Page: 102-110
PDF size: 266.84 Kb.


ABSTRACT

Introduction: Cardiovascular manifestations produced by the arteriovenous fistula in patients treated with hemodialysis are an important aspect, as cardiovascular disease is the leading cause of morbidity and mortality.
Objective: To determine the cardiovascular manifestations in patients with a functional arteriovenous fistula treated with regular hemodialysis.
Method: Descriptive, transversal study, with 81 patients in dialysis treatment who had a functional arteriovenous fistula. Clinical records were reviewed, and a transthoracic echocardiogram was carried out. Association between variables was determined by statistical tests.
Results: There was a significant difference in the hemodialysis treatment time in patients with hypertrophic cardiomyopathy, 70% in less than 4 years against 100% in more than 4 years (p=0.03), valve diseases 67.4 vs. 94.3% (p=0.03), and pulmonary hypertension 26.1 vs. 57.1% (p=0.05); and also regarding the diameter of the left atrium 45.1 ± 4.7 mm, less than 4 years, against 50.9 ± 7.6 mm, more than 4 years (p=0.00). E' wave velocity 7.9 ± 1.4 cm/s vs. 7.2 ± 1.7 cm/s (p=0.045). Interventricular septum 16.4 ± 3.1 mm vs. 18.5 ± 4.9 mm (p=0.021), and posterior wall 14.6 ± 2.5 vs. 16.5 ± 3.1 mm (p=0.003); as well as mean pulmonary artery pressure 25.6 ± 7.5 mmHg vs. 29.3 ± 8.4 mmHg (p=0.042).
Conclusions: No relationship was found between the fistula location and changes in the cardiovascular system. The group of patients with more than four yearsfistula presented major cardiovascular events and significant changes in the echocardiogram.


REFERENCES

  1. Cases A, López Gómez JM, Vera M. Riesgo cardio-vascular en pacientes con insuficiencia renal crónica. Pacientes en tratamiento sustitutivo re-nal. Nefrologia. 2002;22(Supl 1):68-74.

  2. Kshatriya S, Kozman H, Siddiqui D, Bhatta L, Liu K, Salah A, et al. El síndrome cardiorenal en insu-ficiencia cardíaca: Un paradigma en evolución. Rev Chil Cardiol. 2011;31:160-7.

  3. Teixidó J, Ortiz A, Selgas R. Tratamientos sustitu-tivos especiales en la insuficiencia renal terminal: Diálisis Peritoneal. En: Hernando L, Aljama P, Arias M, Caramelo C, Egido J, Lamas S, eds. Ne-frología Clínica. 3ra. Ed. Madrid: Ed. Médica Pana-mericana; 2008. p. 935-61.

  4. MacRae JM, Levin A, Belenkie I. The cardiovas-cular effects of arteriovenous fistulas in chronic kidney disease: a cause for concern? Semin Dial. 2006;19:349-52.

  5. Wasse H, Speckman RA, McClellan WM. Arterio-venous fistula use is associated with lower car-diovascular mortality compared with catheter use among ESRD patients. Semin Dial. 2008;21: 483-9.

  6. Franco Pérez N, Rodríguez Hung S, Telemaque H. Comportamiento de las fístulas arteriovenosas para hemodiálisis en pacientes con insuficiencia renal crónica. Rev Cubana Angiol Cir Vasc [Internet]. 2015 [citado 11 Feb 2016];16:3-8. Disponible en: http://scielo.sld.cu/pdf/ang/v16n1/ang02115.pdf

  7. Llancaqueo M. Síndrome cardiorrenal. Rev Med Clin Condes. 2010;21:602-12.

  8. Bock JS, Gottlieb SS. Cardiorenal syndrome: New perspectives. Circulation. 2010;121:2592-600.

  9. Sipahi I, Fang JC. Treating heart failure on dialysis. Finally getting some evidence. J Am Coll Cardiol. 2010;56:1709-11.

  10. Fernández R, Romero R, Ferrer A. Fístulas arteriovenosas para hemodiálisis: Estudio de un año. AMC [Internet]. 2008 [citado 11 Feb 2015];12. Disponible en: http://scielo.sld.cu/pdf/amc/v12n5/amc11508.pdf

  11. Valderrábano F, Jones EH, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant. 1995;10(Supl. 5):1 - 25.

  12. Roca Tey R. Diagnòstic precoç de l’estenosi de l’accés vascular per hemodiàlisi mitjançant la determinació no invasiva del flux sanguini [Tesis]. España: Universidad Autónoma de Barcelona; 2010.

  13. Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2015;66(Supl. 1):S1-305.

  14. Sánchez González JC. Factores de riesgo asociados a la disfunción de una fístula arteriovenosa en pacientes con enfermedad renal crónica. Enferm Nefrol. 2013;16:104-14.

  15. Jiménez P. Fístulas arteriovenosas para hemodiálisis. Nefrología [Internet]. 2010 [citado 7 Feb 2016]. Disponible en: http://www.revistanefrologia.com/enmonografias- nefrologia-dia-pdf-monografia-38

  16. Collado S, Coll E, Deulofeu R, Guerrero L, Pons M, Cruzado JM, et al. Prevalencia de enfermedad cardiovascular en la uremia y relevancia de los factores de riesgo cardiovascular. Nefrologia. 2010;30:342-8.

  17. Caldés Ruisánchez S, Marcén Letosa R, Amezquita Orjuela Y, Fernández Lucas M, Rivera Gorrin M, Galeano Álvarez C, et al. Inicio de diálisis tras trasplante renal. ¿Se empieza en peor situación que la de los enfermos renales de novo? Nefrologia. 2011;31:51-7.

  18. Marcén R, Morales JM, Fernández-Rodriguez A, Capdevila L, Pallardó L, Plaza JJ, et al. Long-term graft function changes in kidney transplant recipients. NDT Plus. 2010;3(Supl. 2):2-8.

  19. Reinhold C, Haage P, Hollenbeck M, Mickley V, Ranft J. Multidisciplinary management of vascular access for haemodialysis: from the preparation of the initial access to the treatment of stenosis and thrombosis. Vasa. 2011;40:188-98.

  20. González-Álvarez MT, Martínez-Cercós R. Manual de accesos vasculares para hemodiálisis. Barcelona: Editorial Marge Médica Books; 2010.

  21. Valdivia J, Gutiérrez C, Delgado E, Méndez D, Treto J, Fernández I. Epidemiología de la enfermedad renal crónica y los factores de riesgo relacionados con la supervivencia. Invest Medicoquir [Internet]. 2011 [citado 16 Feb 2016];3(1):65-75. Disponible en: http://www.revcimeq.sld.cu/index.php/imq/articl e/view/43/301

  22. Gorostidi M, Santamaría R, Alcázar R, Fernández- Fresnedo G, Galcerán JM, Goicoechea M, et al. Documento de la Sociedad Española de Nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica. Nefrologia. 2014;34:302-16.

  23. Delmonico FL, Domínguez-Gil B, Matesanz R, Noel L. A call for government accountability to achieve national self-sufficiency in organ donation and transplantation. Lancet. 2011;378:1414-8.

  24. Hoerger TJ, Simpson SA, Yarnoff BO, Pavkov ME, Ríos Burrows N, Saydah SH, et al. The Future Burden of CKD in the United States: A simulation model for the CDC CKD Initiative. Am J Kidney Dis. 2015;65:403-11.

  25. Siddiky A, Sarwar K, Ahmad N, Gilbert J. Management of arteriovenous fistulas. BMJ [Internet]. 2014 [citado 11 Feb 2016];349:g6262. Disponible en: http://www.bmj.com/content/349/bmj.g6262

  26. Agarwal AK. Systemic effects of hemodialysis access. Adv Chronic Kidney Dis. 2015;22:459-65.

  27. Miranda-Camarero MV. Cuidados de las fístulas arteriovenosas. Intervenciones y actividades del profesional de enfermería. Dial Traspl. 2010;31:12- 6.

  28. Basile C, Lomonte C, Vernaglione L, Casucci F, Antonelli M, Losurdo N. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant. 2008;23:282-7.

  29. Alkhouli M, Sandhu P, Boobes K, Hatahet K, Raza K, Boobes Y. Cardiac complications of arterio venous fistulas in patients with end-stage renal disease. Nefrologia. 2015;35:234-45.

  30. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham pre-dictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50:217-24.

  31. Barberato SH, Pecoits-Filho R. Alteraciones eco-cardiográficas en pacientes con insuficiencia renal crónica en programa de hemodiálisis. Arq Bras Cardiol. 2010;94:133-9.

  32. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular dis-ease: a statement from the American Heart Asso-ciation Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2008;42:1050-65.

  33. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hyperten-sion: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International So-ciety for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67-119.

  34. Kosmadakis G, Aguilera D, Carceles O, Da Costa Correia E, Boletis I. Pulmonary hypertension in dialysis patients. Ren Fail. 2013;35:514-20.

  35. Bos WJ, Zietse R, Wesseling KH, Westerhof N. Effects of arteriovenous fistulas on cardiac oxy-gen supply and demand. Kidney Int. 1999;55:2049-53.

  36. Bossola M, Tazza L, Vulpio C, Luciani G. Is regres-sion of left ventricular hypertrophy in mainten-ance hemodialysis patients possible? Semin Dial. 2008;21:422-30.

  37. Gómez Pulido F, Gonzales Vargas-Machuca MF, Junco Domínguez MV, Arjona Barrionuevo JD, López Haldón JE, Sánchez González AJ, et al. Hallazgos ecocardiográficos en pacientes con insuficiencia renal crónica terminal en el estudio pretransplante renal. Rev Esp Cardiol. 2010; 63(Supl 3):145 [Resumen].

  38. Raizada V, Skipper B, Taylor RA, Luo W, Harford AA, Zager PG, et al. Left ventricular diastolic function in patients on hemodialysis. J Investig Med. 2010;58:791-5.

  39. Rodríguez Aguirre A. Características de los pa-cientes con enfermedad renal crónica: Estadios I, II, III, IV. Instituto de Ciencias de la Salud [Inter-net]. 2007 [citado 11 Feb 2016]. Disponible en: http://bdigital.ces.edu.co:8080/dspace/bitstream/123456789/370/1/CARACTERISTICAS_PACIENTES_ENFERMEDAD_RENAL.pdf

  40. Unger P, Wissing KM. Arteriovenous fistula after transplantation: utility, futility or threat? Nephrol Dial Transplant. 2006;21:254-7.

  41. Movilli E, Viola BF, Brunori G, Gaggia P, Camerini C, Zubani R, et al. Long-term effects of arteriove-nous fistula closure on echocardiographic func-tional and structural findings in hemodialysis patients: a prospective study. Am J Kidney Dis. 2010;55:682-9.

  42. Assa S, Hummel YM, Voors AA, Kuipers J, Groen H, de Jong PE, et al. Changes in left ventricular diastolic function during hemodialysis sessions. Am J Kidney Dis. 2013;62:549-56.




2020     |     www.medigraphic.com